Myriad Genetics, Inc. recently announced that it has launched myRisk Hereditary Cancer, a new multi-gene diagnostic test that will provide increased sensitivity by analyzing 25 genes associated with eight major cancers including breast, colorectal, ovarian, endometrial, pancreatic, prostate, gastric and melanoma cancer.
New Advances in Treating Hyperpigmentation
This past decade has seen an enormous surge in popularity of skin brightening products formulated specifically to treat hyperpigmentation and…

0 Comments